Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial.

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jun 1988 - 976-82 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0732-183X

10.1200/JCO.1988.6.6.976 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Breast Neoplasms--drug therapy
Clinical Trials as Topic
Cyclophosphamide--adverse effects
Doxorubicin--adverse effects
Epirubicin
Female
Fluorouracil--adverse effects
Heart--drug effects
Humans
Middle Aged
Random Allocation